Trader consensus leans heavily against an Iranian nuclear test before 2027, with "No" shares at 86.5%, driven by IAEA reports confirming no diversion of enriched uranium stockpiles toward weaponization activities despite Iran's near-weapons-grade enrichment to 60%. Recent developments reinforcing this include the IAEA's November 2024 censure of Tehran for lacking cooperation on safeguards, U.S. intelligence assessments stating Iran has not resumed key nuclear weapons work, and Israeli airstrikes degrading Iranian missile capabilities without targeting declared nuclear sites. Stalled JCPOA revival talks amid U.S. political shifts add pressure, though breakout timelines remain months away per experts, underscoring persistent international deterrence over escalation.
Experimental AI-generated summary referencing Polymarket data · UpdatedIran nuclear test before 2027?
Iran nuclear test before 2027?
$113,518 Vol.
$113,518 Vol.
$113,518 Vol.
$113,518 Vol.
A nuclear test is defined as the intentional non-combat detonation of a device by Iran that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by Iran may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to Iran. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to Iran.
The resolution source for this market will be a broad consensus of credible reporting.
Market Opened: Nov 5, 2025, 2:43 PM ET
Resolver
0x65070BE91...A nuclear test is defined as the intentional non-combat detonation of a device by Iran that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by Iran may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to Iran. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to Iran.
The resolution source for this market will be a broad consensus of credible reporting.
Resolver
0x65070BE91...Trader consensus leans heavily against an Iranian nuclear test before 2027, with "No" shares at 86.5%, driven by IAEA reports confirming no diversion of enriched uranium stockpiles toward weaponization activities despite Iran's near-weapons-grade enrichment to 60%. Recent developments reinforcing this include the IAEA's November 2024 censure of Tehran for lacking cooperation on safeguards, U.S. intelligence assessments stating Iran has not resumed key nuclear weapons work, and Israeli airstrikes degrading Iranian missile capabilities without targeting declared nuclear sites. Stalled JCPOA revival talks amid U.S. political shifts add pressure, though breakout timelines remain months away per experts, underscoring persistent international deterrence over escalation.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions